Advertisement
Circulating tumor cell assays may have a role in the management of bladder cancer

Circulating Tumor Cell Assays May Play Role in Managing Bladder CA

0
IsoFlux test showed 10 or more circulating tumor cells in four of nine samples, versus 0 with CellSearch
Live and recorded perioperative music therapy reduces anxiety in patients undergoing surgery for potential or known breast cancer

Music Reduces Anxiety Score in Breast Cancer Surgery Patients

0
Reduction in anxiety scores preoperatively with live or recorded music versus usual care
Too few members of certain minority groups are pursuing careers in U.S. medicine

Too Few Blacks, Hispanics Pursuing Careers As Physicians

0
Shortage of minority physicians may affect U.S. patient care, experts say
Regularly taking low-dose aspirin or other nonsteroidal anti-inflammatory drugs may lower long-term risk of colorectal cancer

Low-Dose Aspirin, Other NSAIDs May Lower Colorectal Cancer Risk

0
Findings for consistent use over 5 or more years
Women tend to manage their femininity so as to be considered adherent to the unspoken code of the non-gendered worker

Women in Academic Medicine ‘Manage Femininity’ to Succeed

0
Strategies for this include appearing easy-going or downplaying differences based on gender
Acupuncture appears to be more efficacious than oral medication for treating hot flashes in breast cancer survivors

Acupuncture Beats Pills for Hot Flashes in Breast CA Survivors

0
Even 'sham' acupuncture beat one frequently used medication
In veterans

Veterans Have Poor Oral, Throat Cancer Outcomes

0
In oropharyngeal squamous cell carcinoma, overall survival at five years is 40 percent
Nonselective beta-blocker use is associated with improved overall survival among patients with epithelial ovarian

Nonselective Beta-Blocker Use Ups Survival in Ovarian Cancers

0
Longer median overall survival for patients receiving any beta-blocker versus nonusers
U.S. Food and Drug Administration approval of the drug Promacta (eltrombopag) has been expanded to include children 1 year and older with chronic immune thrombocytopenic purpura.

Promacta Approval Expanded for Children With Chronic ITP

0
Builds on recent approval for ages 6 years and up for chronic immune thrombocytopenic purpura
Practices can employ patient and family advisors in order to help them focus on patient-centered care needs

Patient, Family Advisors Can Play Key Role in Practices

0
Advisors can help practices focus on patient-centered care, rather than assumptions about patient needs